Orally and nasally induced tolerance studies in ocular inflammatory disease: Guidance for future interventions

Annals of the New York Academy of Sciences

Volumn 1029, Issue , 2004, Pages 278-285

  Nussenblatt, Robert ^a  

^a NATIONAL EYE INSTITUTE   (United States)

Author keywords

Corneal engraftment; Nasal tolerance; Oral tolerance; Uveitis

Indexed keywords

HLA ANTIGEN CLASS 1; RETINA ANTIGEN; RETINA S ANTIGEN;

CLINICAL TRIAL; CONFERENCE PAPER; CORNEA TRANSPLANTATION; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOPATHOGENESIS; NONHUMAN; UVEITIS;

EID: 14544290432     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1309.058     Document Type: Conference Paper

References (18)

1. CASPI, R.R. 2002. Th1 and Th2 responses in pathogenesis and regulation of experimental autoimmune uveoretinitis. Int. Rev. Immunol. 21: 197-208.
2. NUSSENBLATT, R.B. 2002. Bench to bedside: new approaches to the immunotherapy of uveitis disease. Int. Rev. Immunol. 21: 273-289.
3. NUSSENBLATT, R.B. et al. 1980. Cellular immune responsiveness of uveitis patients to retinal S-antigen. Am. J. Ophthalmol. 89: 173-179.
4. DE SMET, M.D. et al. 2001. Human S-antigen determinant recognition in uveitis. Invest. Ophthalmol. Vis. Sci. 42: 3233-3238.
5. NUSSENBLATT, R.B. et al. 1990. Inhibition of S-antigen induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-antigen. J. Immunol. 144: 1669-1695.
6. HE, Y.G., J. MELLON & J.Y. NIEDERKORN. 1996. The effect of oral immunization on corneal allograft survival. Transplantation 61: 920-926.
7. SUH, E. et al. 1993. Splenectomy abrogates the induction of oral tolerance in experimental autoimmune uveoretinitis. Curr. Eye Res. 12: 833-839.
8. GREGORSON, D.S. et al. 1990. Identification of a potent new pathogenic side in human retinal S-antigen which induces experimental autoimmune uveoretinitis in LEW rats. Cell Immunol. 128: 209-219.
9. THURAU, S.R. et al. 1991. Induction of oral tolerance to S-antigen induced experimental autoimmune uveitis by a uveitogenic 20mer peptide. J. Autoimmun. 4: 507-516.
10. WILDNER, G. & S.R. THURAU. 1994. Cross-reactivity between an HLA-B27 derived peptide and a retinal autoantigen peptide: a clue to major histocompatibility complex association with autoimmune disease. Eur. J. Immunol. 24: 2579-2585.
11. THURAU, S.R. & G. WILDNER. 2003. An HLA-peptide mimics organ-specific antigen in autoimmune uveitis: its role in pathogenesis and therapeutic induction of oral tolerance. Autoimmun. Rev. 2: 171-176.
12. HU, W. et al. 1998. Experimental mucosal induction of uveitis with the 60-kDa heat shock protein-derived peptide 336-351. Eur. J. Immunol. 28: 2444-2455.
13. DICK, A.D. et al. 1993. Nasal administration of retinal antigens suppresses the inflammatory response in experimental allergic uveoretinitis. Br. J. Ophthalmol. 77: 171-175.
14. KREUTZER, B. et al. 1977. Nasal administration of retinal antigens maintains immunosuppression of uveoretinitis in cyclosporin-A-treated Lewis rats: future treatment of endogenous posterior uveoretinitis. Eye 11: 445-452.
15. DICK, A.D. et al. 1998. Effects of mycophenolate mofetil on nasal mucosal tolerance induction. Invest. Ophthalmol. Vis. Sci. 39: 835-840.
16. NUSSENBLATT, R.B. et al. 1997. Treatment of uveitis by oral administration of retinal antigens: results of a Phase I/II randomized masked trial. Am. J. Ophthalmol. 123: 583-592.
17. THURAU, S.R. et al. 1997. Molecular mimicry as a therapeutic approach for an autoimmune disease: oral treatment of uveitis-patients with an MHC-peptide crossreactive with autoantigen-first results. Immunol. Lett. 57: 193-201.
18. THURAU, S.R. et al. 1999. Oral tolerance with an HLA-peptide mimicking retinal autoantigen as a treatment of autoimmune uveitis. Immunol. Lett. 68: 205-212.